RNA interference(RNAi) is a highly conserved process in eukaryotes that is responsible for transposon silencing, gene regulation and antiviral response. During RNAi process, double-stranded RNAs (dsRNAs) are cleaved by Dicer into 20-26 nucleotide long primary short interfering RNAs (siRNAs). Then these primary siRNAs guide specific RNA binding proteins, Argonautes, to target mRNAs and recruit RNA-dependent RNA polymerases (RdRPs) to produce secondary siRNAs (22G-RNAs), which directly silences target mRNAs. Previous Dicer Immunoprecipitation discovered an RNA polyphosphatase PIR-1 interacting with Dicer, who may participate in RNAi but the mechanism is unrevealed. The project is to investigate the functions and mechanism of PIR-1 in RNAi pathways. First, we elucidated that the in vitro activity of recombinant C. elegans PIR-1 purified using bacteria is to remove beta and ? phosphates from the 5' end of triphosphorylated RNA molecule. And Electrophoretic Mobility Shift Assay(EMSA) shows that catalytically dead PIR-1(C150S) has no RNA polyphosphatase activities but binds the substrate tightly. Second, we investigate the role of PIR-1 in antiviral RNAi. Orsay virus propagation enrichment in infected
pir-1 null mutant suggests that PIR1 is significant for antiviral RNAi response to Orsay virus. dsRNA extraction and strand-specific qPCR results show that viral dsRNAs are depleted in
pir-1 null mutant but not in other RNAi deficient mutants such as
rde-1,
rde-3 or
dcr-1, which indicated that PIR-1 is involved in dsRNAs processing. We are constructing the
pir-1;
dcr-1 double mutant to understand the specific roles of PIR-1 in dsRNAs stability and cleavage. Since catalytically dead PIR-1 still binds substrate RNAs, we are preparing FLAG-tagged catalytically dead PIR-1 using CRISPR/Cas9 to identify the in vivo substrate of PIR-1. Third, our preliminary study revealed that PIR-1 is required for synthesis of endogenous siRNAs (26G-RNAs) which targets thousands of genes in germline cells and early embryos. We are using genetics and high-throughput sequencing to dissect the role of PIR-1 in these RNAi-mediated pathways.